Inventage Lab (XKRX:389470) Change In Receivables : ₩-123.6 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab Change In Receivables?

Inventage Lab's change in receivables for the quarter that ended in Mar. 2024 was ₩0.0 Mil. It means Inventage Lab's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Inventage Lab's change in receivables for the fiscal year that ended in Dec. 2023 was ₩-123.6 Mil. It means Inventage Lab's Accounts Receivable increased by ₩123.6 Mil from Dec. 2022 to Dec. 2023 .

Inventage Lab's Accounts Receivable for the quarter that ended in Mar. 2024 was ₩0.0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Inventage Lab's Days Sales Outstanding for the three months ended in Mar. 2024 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Inventage Lab's liquidation value for the three months ended in Mar. 2024 was ₩-35,876.6 Mil.

Inventage Lab Change In Receivables Historical Data

The historical data trend for Inventage Lab's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab Change In Receivables Chart

Inventage Lab Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

-3.68

-45.92

-2,637.44

2,310.11

-123.57

Inventage Lab Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial					-11.76	-11.06	-343.97	243.22	-

Inventage Lab Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-123.6 Mil.

Inventage Lab (XKRX:389470) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Inventage Lab's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	96.928	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, Inventage Lab's accounts receivable are only considered to be worth 75% of book value:

Inventage Lab's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0	-	35876.588	+	0.75 * 0	+	0.5 * 0
=	-35,876.6

Inventage Lab Change In Receivables Related Terms

Thank you for viewing the detailed overview of Inventage Lab's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Inventage Lab (XKRX:389470) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403

Website

https://www.inventagelab.com

Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines